Gastroesophageal Reflux Disease (GERD) Market Forecast Reaching $5.94 Billion by 2029 at 3% CAGR
Discover trends, market shifts, and competitive outlooks for the gastroesophageal reflux disease (gerd) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What is the Projected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Size from 2025 to 2034?#_x000D_
In recent times, a slight increase has been noted in the market size of gastroesophageal reflux disease (GERD). The market growth is projected to rise from $5.25 billion in 2024 to $5.35 billion in 2025, with a compound annual growth rate (CAGR) of 2.0%. Factors contributing to this growth during the historical period include changes in lifestyle and diet, an obesity epidemic, heightened understanding of GERD treatment, globalization in the pharmaceutical sector, and capital investments made towards GERD treatments._x000D_
_x000D_
In the coming years, the market for gastroesophageal reflux disease (GERD) is projected to witness a stable increase. By 2029, the market is anticipated to escalate to a value of $5.94 billion, expanding at a compound annual growth rate (CAGR) of 2.7%. The surge during this forecast period is linked to factors such as an aging demographic, augmented healthcare expenses, the rise of biomarkers, an increased variety of screening programs for GERD, a growing rate of heartburn cases, and heightened demand for medical equipment. Key trends for this forecast period encompass advancements in diagnostics and surgery, the evolution of targeted treatments, and the widespread adoption of telehealth services._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp_x000D_
_x000D_
#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gastroesophageal Reflux Disease (GERD) Market?#_x000D_
The market for gastroesophageal reflux disease (GERD) anticipates growth due to an expected increase in the incidence of esophageal diseases. These specific ailments primarily target the muscular conduit that serves as a bridge between the mouth and stomach, the esophagus. Treatment strategies for these diseases aim to reduce discomfort, enhance the quality of life, and inhibit further complications, thereby encouraging improved overall health for individuals afflicted with gastroesophageal reflux disease. The American Cancer Society, a US professional organization, reported in January 2023 the diagnosis of approximately 21,560 new cases of esophageal cancer annually in the United States, culminating in 16,120 mortalities. Therefore, the increasing occurrence of esophageal diseases propels the growth of the gastroesophageal reflux disease (GERD) market.
Gastroesophageal Reflux Disease (GERD) Market Driver: The Implication of Alcohol Consumption on the Expansion of the Gastroesophageal Reflux Disease (GERD) Market
_x000D_
_x000D_
#Which Key Market Segments Comprise the Gastroesophageal Reflux Disease (GERD) Market and Drive Its Revenue Growth?#_x000D_
The gastroesophageal reflux disease (GERD) market covered in this report is segmented –_x000D_
_x000D_
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)_x000D_
2) By Procedure: Invasive, Minimally Invasive_x000D_
3) By End-Users: Hospital, Homecare, Specialty Clinics_x000D_
_x000D_
Subsegments:_x000D_
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide_x000D_
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole_x000D_
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine_x000D_
4) By Prokinetic Agents: Metoclopramide, Domperidone_x000D_
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol_x000D_
6) By EndoCinch: Endoscopic Suturing Systems_x000D_
7) By Stretta: Radiofrequency Ablation Systems_x000D_
8) By EsophyX: Transoral Fundoplication Systems_x000D_
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp_x000D_
_x000D_
#Which Areas Are Leading Regions in the Gastroesophageal Reflux Disease (GERD) Market Expansion Across the Globe?#_x000D_
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
#What Are the Key Market Trends in theGastroesophageal Reflux Disease (GERD) Market Over the Coming Years?#_x000D_
Leading businesses in the gastroesophageal reflux disease (GERD) market are strategizing to retain their market dominance by introducing state-of-the-art GERD treatment devices. For example, in April 2023, Laborie Medical Technologies, a medical technology enterprise based in the US, unveiled alpHaONE, a groundbreaking wireless pH-capsule reflux diagnostics system tailored for the detection of gastroesophageal reflux disease (GERD). This system delivers up to 96 hours of monitoring data and possesses a compact structure with broadened buttons and a reliable capsule delivery mechanism. It also incorporates a software application that presents a virtual instruction module and personalized symptom buttons to enhance the user experience._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Gastroesophageal Reflux Disease (GERD) Market Conceptually Defined?#_x000D_
Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back into the esophagus, causing irritation and discomfort. The treatment for the disease includes various medical strategies and interventions employed to manage the symptoms and complications associated with gastroesophageal reflux disease._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12917_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
